1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CONTRAFECT CORP

ContraFect Corp

XNAS: CFRX

Watchlist

Portfolio

Share


Insider Trading disclosures for ContraFect Corp

The latest disclosure was made by Michael Messinger in ContraFect Corp where a trade of 25,000 Options (Right to Buy) done was reported to US exchanges on Feb. 14, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Messinger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 25,000 25,000 - - Options (Right to Buy)
Cary W. Sucoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Steven C. Gilman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Michael J. Otto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
David N. Low Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Lishan Aklog Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 42,000 42,000 - - Options (Right to Buy)
Roger J. Pomerantz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 500,000 500,000 - - Options (Right to Buy)
Michael Messinger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 165,000 165,000 - - Options (Right to Buy)
Natalie Bogdanos General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 125,000 125,000 - - Options (Right to Buy)
Cara Cassino Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 160,000 160,000 - - Options (Right to Buy)
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
Steven C. Gilman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
Michael J. Otto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
Cary W. Sucoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
David N. Low Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
Lishan Aklog Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 25,000 25,000 - - Options (Right to Buy)
Michael Messinger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 80,000 80,000 - - Options (Right to Buy)
Roger J. Pomerantz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 254,000 254,000 - - Options (Right to Buy)
Natalie Bogdanos General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 70,000 70,000 - - Options (Right to Buy)
Cara Cassino Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 90,000 90,000 - - Options (Right to Buy)
Cara Cassino Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 80,000 80,000 - - Options (Right to Buy)
Jane F. Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2021 16,000 16,000 - - OPTIONS (RIGHT TO BUY)
Lishan Aklog None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2020 16,000 16,000 - - Options (Right to Buy)
Michael Messinger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 75,000 75,000 - - Options (Right to Buy)
Michael Messinger Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.37 per share. 13 Dec 2019 5,000 19,091 (0%) 0% 0.4 1,850 Common Stock, par value $0.0001 per share
David N. Low None Purchase of securities on an exchange or from another person at price $ 0.43 per share. 13 Dec 2019 300,000 370,550 (0%) 0% 0.4 129,000 Common Stock, par value $0.0001 per share
Cary W. Sucoff None Purchase of securities on an exchange or from another person at price $ 0.39 per share. 13 Dec 2019 50,000 62,000 (0%) 0% 0.4 19,500 Common Stock, par value $0.0001 per share
Natalie Bogdanos General Counsel Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 800 800 (0%) 0% 1.2 992 Common Stock, par value $0.0001 per share
Cara Cassino Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 4,000 4,000 - - Warrants (Right to Buy)
Cara Cassino Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 8,000 8,000 (0%) 0% 1.2 9,920 Common Stock, par value $0.0001 per share
Joshua Muntner SVP Business Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 1,000 1,000 - - Warrants (Right to Buy)
Joshua Muntner SVP Business Development Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 2,000 2,000 (0%) 0% 1.2 2,480 Common Stock, par value $0.0001 per share
Natalie Bogdanos General Counsel Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 400 400 - - Warrants (Right to Buy)
Michael Messinger SVP Finance Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 400 400 - - Warrants (Right to Buy)
Sol J. Barer None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 40,000 815,933 (1%) 0% 1.2 49,600 Common Stock, par value $0.0001 per share
Sol J. Barer None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 20,000 20,000 - - Warrants (Right to Buy)
Steven C. Gilman Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 400 400 - - Warrants (Right to Buy)
Steven C. Gilman Director, CEO Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 800 20,800 (0%) 0% 1.2 992 Common Stock, par value $0.0001 per share
Lisa Ricciardi None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 9,600 9,600 (0%) 0% 1.2 11,904 Common Stock, par value $0.0001 per share
Lisa Ricciardi None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 4,800 4,800 - - Warrants (Right to Buy)
Michael J. Otto None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 8,000 8,000 (0%) 0% 1.2 9,920 Common Stock, par value $0.0001 per share
Michael J. Otto None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 4,000 4,000 - - Warrants (Right to Buy)
Isaac Blech None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 16,000 16,000 (0%) 0% 1.2 19,840 Common Stock, par value $0.0001 per share
Cary W. Sucoff None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 12,000 12,000 (0%) 0% 1.2 14,880 Common Stock, par value $0.0001 per share
Cary W. Sucoff None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 6,000 6,000 - - Warrants (Right to Buy)
David N. Low None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 40,000 70,550 (0%) 0% 1.2 49,600 Common Stock, par value $0.0001 per share
David N. Low None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 20,000 20,000 - - Warrants (Right to Buy)
Roger J. Pomerantz None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 400 400 - - Warrants (Right to Buy)
Roger J. Pomerantz None Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 800 800 (0%) 0% 1.2 992 Common Stock, par value $0.0001 per share
Michael Messinger SVP Finance Purchase of securities on an exchange or from another person at price $ 1.24 per share. 25 Jul 2017 800 14,091 (0%) 0% 1.2 992 Common Stock, par value $0.0001 per share
Isaac Blech None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Jul 2017 8,000 8,000 - - Warrants (Right to Buy)
Steven C. Gilman Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jul 2016 20,000 20,000 - - Common Stock, par value $0.0001 per share
Steven C. Gilman Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jul 2016 20,000 20,000 - - Warrants (Right to Buy)
Nancy Dong VP Controller Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Dec 2015 3,333 0 - - Class B Warrants (Right to Buy)
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2015 2,872 0 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Nov 2015 2,867 2,872 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Oct 2015 2,867 5,739 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Oct 2015 2,867 8,606 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2015 2,867 11,473 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Sep 2015 2,867 14,340 - - Common Stock, par value $0.0001 per share
Julia P. Gregory CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Mar 2015 11,778 50,283 - - Common Stock, par value $0.0001 per share
Julia P. Gregory CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 29,946 38,505 - - Common Stock, par value $0.0001 per share
Nancy Dong VP Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 6,287 15,161 - - Common Stock, par value $0.0001 per share
Michael Messinger VP Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 13,291 13,291 - - Common Stock, par value $0.0001 per share
Barry Kappel SVP Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 12,532 12,532 - - Common Stock, par value $0.0001 per share
Daniel Couto SVP Manufacturing & Facilities Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 17,207 17,207 - - Common Stock, par value $0.0001 per share
Michael Wittekind Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 17,893 17,893 - - Common Stock, par value $0.0001 per share
David Huang Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2014 23,901 23,901 - - Common Stock, par value $0.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters